Burger, Cyrill (PMOD Technologies 201907 CEO) |
Chief Executive Officer (CEO) |
Bruker (Group) |
Switzerland |
Burger, Joachim (Univ Mainz 201211 Professor) |
Professor |
University of Mainz (Johannes Gutenberg University) |
Germany |
Burgermeister, Patrick (Forever Healthy 202201 Partner at Kizoo TV formerly Apeiron before Novartis) |
Business Development Manager / Strategy Manager |
Forever Healthy (Kizoo / Michael Greve) (Group) |
Germany |
Burgess, Mike (BMS 201301– SVP Discovery Medicine + Clinical Pharmacology before Roche) |
Research & Development Manager |
Bristol Myers Squibb (BMS) (Group) |
United States (USA) |
Burgess, Rob (RayBiotech 201408 VP Business Development before Stem Cell Sciences) |
Business Development Manager / Strategy Manager |
RayBiotech Inc. |
United States (USA) |
Burgstaller, Petra (BioM 202001 Senior Manager Start-ups + Funding) |
Cluster Manager |
Bavaria (govt region) |
Germany |
Burian, Rainer C. (PAA Laboratories GmbH 201108 Managing Director) |
Managing Director |
General Electric (Group) |
Austria |
Burkamp, Frank (Almac 201206 Senior Investigator) |
Researcher (industry) |
Almac (Group) |
United Kingdom (GB) |
Burnet, Michael (Synovo GmbH 201109 Managing Director) |
Managing Director |
Synovo GmbH |
Germany |
Burnet, Renate (Synovo GmbH 201710 Business Development) |
Business Development Manager / Strategy Manager |
Synovo GmbH |
Germany |
Burns, Alasdair A. (Microstein LLC 201208 CEO) |
Chief Executive Officer (CEO) |
Microstein LLC |
United States (USA) |
Burns, James W. (Jim) (Locana 201912– before Casebia Therapeutics + Sanofi-Genzyme + MassBio) |
Chief Executive Officer (CEO) |
Locanabio Inc. |
United States (USA) |
Burns, Robert F. (4-Antibody 201101– CEO before Affitech CEO before Celldex Therapeutics CEO) |
Chief Executive Officer (CEO) |
Agenus (Group) |
Switzerland |
Burns, Rowena (Manchester Science Partnerships 201208– CEO + 201807 Chair of Health Innovation Manchester) |
Cluster Manager |
Summit (Group) |
United Kingdom (GB) |
Burns, William M. (Roche 200207–200904– CEO Pharma division) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
Burow, Martin (GATC Biotech 201011– Head Commercial Operations LifeCodexx AG before Brahms AG Sales Manager Asia) |
Chief Commercial Officer (CCO) |
Eurofins (Group) |
Germany |
Burrows, Jon (Oxford BioDynamics 202011 CEO formerly Expression Pathology + Ventana + Novartis + Chiron) |
Chief Executive Officer (CEO) |
Oxford BioDynamics (Group) |
United Kingdom (GB) |
Burziwoda, Dominik (Perfood 202011 Managing Director (CEO) + Co-Founder) |
Managing Director |
Perfood GmbH |
Germany |
Busch, Andreas (Bayer 201201–201711 Head Global Drug Discovery at Bayer Healthcare LEFT 11/17) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
Busch, Katja (BioCon Valley 202201 Project Manager Healthcare Marketing + Network Management) |
Cluster Manager |
BioCon Valley GmbH |
Germany |
Buschmann, Helmut (Savira Pharmaceuticals 201210 CSO) |
Chief Executive Officer (CEO) |
Savira Pharmaceuticals GmbH |
Austria |
Bushell, Mike (Syngenta 200502) |
n. a. |
Syngenta (Group) |
Switzerland |
Busmalis, Christina (BenevolentAI 202309– Chief Revenue Officer before Google + IBM Watson Health + IBM + PwC) |
Chief Commercial Officer (CCO) |
BenevolentAI (Group) |
United Kingdom (GB) |
Buss, Tony (MerLion –200707– CEO) |
Chief Executive Officer (CEO) |
MerLion (Group) |
Singapore |
Busse, Falko (Bruker Corp 201805– President of Bruker BioSpin Group joined 2015 before Philips Healthcare) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
Busse, Wolf-Dieter (Aerovance 200408– CEO before Bayer SVP Biotech) |
Chief Executive Officer (CEO) |
Aerovance Inc. |
United States (USA) |
Buth, Ines-Regina (akampion 200901 before Micromet Head Investor Relations before Lion Bioscience) |
Public Relations Manager / Investor Relations Manager |
Akampion |
Germany |
Butler, Lynn (Sirenade Pharmaceuticals 200407– CEO before Swentibold before Devgen) |
Chief Executive Officer (CEO) |
KeyNeurotek (Group) |
Germany |
Butscheid, Yulia (Biognosys 201304– Head Strategy + Business Development before Creathor Venture + Novartis) |
Business Development Manager / Strategy Manager |
Bruker (Group) |
Switzerland |
Butscher, Philipp (Berliner Effektengesellschaft 201205 Associate at Ventegis Capital AG) |
n. a. |
Berliner Effektengesellschaft (Group) |
Germany |
Buttar, Rabinder (ClinTec 1997– CEO + Founder) |
Chief Executive Officer (CEO) |
ClinTec (Group) |
United Kingdom (GB) |
Butterfield, Stewart (Slack Technologies 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Salesforce (Group) |
United States (USA) |
Buttkereit, Monika (Biotest 201308 Head of Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Grifols (Group) |
Germany |
Buyse, Chris (Fund+ 201610 Managing Partner before ThromboGenics 201203 CFO) |
Managing Partner |
Fund+ N.V. |
Belgium |
Büchele, Wolfgang (Exyte 202207 CEO formerly Linde 201405 designated CEO + Board Chairman of Merck KGaA) |
Chief Executive Officer (CEO) |
Stumpf (Group) |
Germany |
Büchler, Andrea (Lunaphore 201808 Finance + Business Development) |
Business Development Manager / Strategy Manager |
Bio-Techne (Group) |
Switzerland |
Byczynski, Michael (Eppendorf 200803) |
n. a. |
Eppendorf (Group) |
Germany |
Bügling, Dieter (Polyplan GmbH 200902 Managing Director) |
Managing Director |
Polyplan (Group) |
Germany |
Bühler, Markus (Technologiepark Heidelberg 201504 Startup Support Manager) |
n. a. |
Heidelberg (govt city) |
Germany |
Bühler, Peter (Valneva 202107– CFO ANNOUNCED before Quotient + Zaluvida + Stallergenes Greer + Lilly + Merck Serono) |
Chief Financial Officer (CFO) |
Valneva (Group) |
France |
Bülow, Holger (Miltenyi 201901 Press Contact) |
Public Relations Manager / Investor Relations Manager |
Miltenyi Biotec (Group) |
Germany |
Bülow, Sven (Eppendorf 201104 EVP Corporate Developm before Director Eppendorf Biochip Systems) |
Business Development Manager / Strategy Manager |
Eppendorf (Group) |
Germany |
Büntemeyer, Heino (TeutoCell 201105 Executive Board Member) |
Board member, executive |
Xell AG |
Germany |
Bünz, Alexander (Knauer 2006–2014 Managing Director LEFT 2015) |
Managing Director |
Knauer (Group) |
Germany |
Bürger, Frank (Avida Group 200508 before WGZ-Bank) |
n. a. |
AVIDA Group (Dusseldorf) |
Germany |
Bürger, Mario (GeSiM 200604 Managing Director) |
Managing Director |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
Bürgermeister, Torsten (Veraxa Biotech 202203– CFO before Molecular Health) |
Chief Financial Officer (CFO) |
Veraxa Biotech (Group) |
Germany |
Bürk, Jan-Hendrik (btov Partners 202010 Principal) |
Principal (venture capital) |
btov Partners (b-to-v Partners) (Group) |
Germany |
Bürk, Matthias (Merck (DE) 201409 Head of Human Resources Germany) |
Human Resources Manager |
Merck (DE) (Group) |
Germany |
Bürling, Philipp (Priavoid 202009– CEO formerly Numaferm GmbH 201702– Managing Director + Co-Founder) |
Chief Executive Officer (CEO) |
Priavoid GmbH |
Germany |
Bürmann, Martin (Rittershaus 200809 Mannheim) |
n. a. |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
Bürsgens, Federico (GNA Biosolutions 201908 Managing Director + Co-Founder) |
Managing Director |
GNA Biosolutions GmbH |
Germany |
Bütow, Sandra M. (Germany (govt) 201504 Senior Manager MedTech + Medical Biotech + Pharma at GTAI) |
n. a. |
Germany (govt) |
Germany |
Büttiker, Mathis (Endress+Hauser 201706– Supervisory Board Member main org Notenstein La Roche Privatbank AG) |
Supervisory Board Member |
Endress+Hauser (Group) |
Switzerland |
Bähr, Christa (CB Healthcare 201804) |
Analyst (Financial / Industry) |
CB Healthcare – Dr. Christa Bähr |
Germany |
Bähr, Cornelia (b.value 202104 Investment Manager) |
Investment Manager |
b.value (Group) |
Germany |
Bähr, Petra (Priaxon 200805 CEO) |
Chief Executive Officer (CEO) |
Priaxon AG |
Germany |
Bär, Lars (Celldeg GmbH 201609– Managing Director) |
Managing Director |
Celldeg GmbH |
Germany |
Bärsch, Niko (Particular GmbH 201105 Managing Director) |
Managing Director |
Particular GmbH |
Germany |
Bässmann, Carsten (Bruker 201306 Head of ESI Applications Development) |
Research & Development Manager |
Bruker (Group) |
United States (USA) |
Bäuerle, Patrick (MPM Capital 201710 Managing Director formerly Micromet) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
Böge, Henning (Capical GmbH 201109 Managing Director + co-founder) |
Managing Director |
Capical GmbH |
Germany |
Böhm, Christian (NLC Venture 202210 Venture Partner) |
Venture Partner |
NLC Ventures (Group) |
Netherlands |
Böhm, Gerald (BIO-NET Leipzig 201210 Managing Director) |
Managing Director |
BIO-NET Leipzig Technologietransfergesellschaft mbH (Bio City Leipzig) |
Germany |
Böhme, Harry (c-LEcta GmbH 201509– CFO before CFO at Novaled AG) |
Chief Financial Officer (CFO) |
Kerry Group (Group) |
Germany |
Böhme, Marc (Amedo 201003– Managing Director responsible for Sales + Marketing) |
Managing Director |
Amedo Smart Tracking Solutions GmbH |
Germany |
Böhme, Silvana (Biostep 200512) |
n. a. |
Biostep GmbH |
Germany |
Bölke, Tim P. (BASF 201012 Managing Director of Metanomics Health GmbH) |
Managing Director |
Acousia Therapeutics GmbH |
Germany |
Bördgen, Anke (Knauer 201403 Head of Product Management) |
Product Manager (personnel) |
Knauer (Group) |
Germany |
Börnsen, Jens (Bremen (govt) 201308 Major) |
n. a. |
Bremen (govt region) |
Germany |
Bös, Michael (Acousia Therapeutics 201805 CSO before Affectis + Boehringer Ingelheim Canada) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Acousia Therapeutics GmbH |
Germany |
Bösche, Bernd (Schleswig-Holstein 201012 Managing Directort WTSH) |
Managing Director |
Schleswig-Holstein (govt region) |
Germany |
Bösenberg, Sabine (Aviso 200809) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
Germany |
Bösl, Raphael (Isenbruck Bösl Hörschler 201511 Patent Attorney) |
Patent Attorney |
Isenbruck | Bösl | Hörschler LLP |
Germany |
Böttcher, Ute (GenExpress GmbH 201102 Managing Director) |
Managing Director |
GenExpress Gesellschaft für Proteindesign mbH |
Germany |
Böttcher-Lorenz, Juliane (MVZ für Mikrobiologie Dessau 200909 Managing Director) |
Managing Director |
MVZ für Mikrobiologie, Labordiagnostik und Hygiene Dessau GmbH |
Germany |
Cabirol, Fabien (L’Oréal 201501 Global Head of Biotechnologies Dept) |
President/Director/Head Business Group/Unit/Division |
L’Oréal (Group) |
France |
Cafazzo, Mark (Danaher 201601 Director Academic + Clinical Research Business at Sciex) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
Cagnoni, Pablo J. (Rubius Therapeutics 202207 CEO before MPM Capital + Tizona Tx + Blade Tx + OSI Pharma) |
Chief Executive Officer (CEO) |
MPM Capital (Group) |
United States (USA) |
Cai, Darren (Legend Capital 201706 Managing Director) |
Managing Director |
Legend Capital (CN) |
China |
Calais, Philippe (Antisense Pharma 201205– Managing Director CEO before Roche + ICI et al) |
Managing Director |
Isarna Therapeutics GmbH |
Germany |
Calaman, Greg (Definiens 200604– VP North America Operations) |
n. a. |
AstraZeneca (Group) |
Germany |
Calikowski, Tomasz (EU 201403 Scientific Officer of European Commission) |
Administrative Officer (personnel) |
|
|
Calleja, Montserrat (CSIC 201302 Dept Head at Bionanomechanics lab at IMM) |
Researcher (university / research institute) |
Spain (govt) |
Spain (España) |
Calzolari, Simone (ZeClinics 202102 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
ZeClinics (ES) |
Spain (España) |
Camardo, Joseph (Joe) (ADC Therapeutics 202206 CMO formerly Wyeth Pharma 200704 SVP of Global Medical Affairs) |
Chief Medical Officer (CMO) |
Pfizer (Group) |
United States (USA) |
Camblong, Jurgi (Sophia Genetics 201407 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
Switzerland |
Cameron, Grant (Automation Partnership 201210 RAFT Development Director) |
Research & Development Manager |
Sartorius (Group) |
United Kingdom (GB) |
Caminelli, Silvano |
n. a. |
HBM (Group) |
Switzerland |
Campos, Renata (Takeda 201502 Managin Diretor Turkey) |
Managing Director |
Takeda (Group) |
Japan |
Canet, Emmanuel (Servier 200705 VP RnD) |
research & development (RnD, research and development) |
Servier (Group) |
France |
Cansier, Alexander (PANATecs 201003 Head Quality Assurance) |
n. a. |
Zukunftsfonds Heilbronn (Group) |
Germany |
Cantarell, Luis (Nestlé 201105 CEO of Nestlé Health Science SA) |
Chief Executive Officer (CEO) |
Nestlé (Group) |
Switzerland |
Cantey, Danielle (UDG Healthcare 202108 at Canale Communciations before WPP 201909 Glover Park Group) |
Public Relations Manager / Investor Relations Manager |
Inizio (Group) |
United States (USA) |
Canton, Barry (Ginkgo Bioworks 202203 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Ginkgo Bioworks (Group) |
United States (USA) |
Capone, Mark C. (Myriad Genetics 201605 CEO) |
Chief Executive Officer (CEO) |
Myriad Genetics (Group) |
United States (USA) |
Cappia, Jean-Marc (201006 VP Marketing Fluid Management Technologies at Sartorius Stedim Biotech) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
France |
Cardella, Craig (Scienion 201112– Manager of Sciencion US Inc before Matrical Bioscience) |
General Manager (management) |
Bico (Group) |
United States (USA) |
Cardoen, Johan (VIB 201501 Managing Director) |
Managing Director |
VIB (Flanders Interuniversity Institute for Biotechnology / Vlaams Instituut voor Biotechnologie) |
Belgium |
Carell, Thomas (LMU 201410 Professor for Organic Chemistry + Founder of Baseclick GmbH) |
Professor |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |